Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Michael P. Michaud who wrote (54668)	1/24/2004 2:18:51 PM
From: Pogeu Mahone	Respond to of 54805

Message 19728452

To: Michael P. Michaud who wrote (54668)	1/26/2004 3:33:42 PM
From: JMarcus	Respond to of 54805

I'm new to PHYX, having only discovered it at last week's JM Dutton Healthcare Conference. I posted my notes on their presentation here: Message 19734232 Marc

To: Michael P. Michaud who wrote (54668)	2/6/2004 1:17:22 PM
From: Pogeu Mahone	Respond to of 54805

i think they wilol be good Press Release Source: Physiometrix, Inc. Physiometrix to Report Fourth-Quarter Financial Results February 12, 2004 Friday February 6, 12:24 pm ET NO. BILLERICA, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Physiometrix, Inc. (Nasdaq-SCM: PHYX) will hold a telephone conference call to discuss fourth- quarter 2003 financial results, as well as management's comments related to the Company's business, at 11:00 A.M. (Eastern) on February 12, 2004. The call number is 800-465-7133, conference ID # 5441473. A replay of the conference call will be available after conclusion of the conference call until 11:59 P.M. (Eastern) on Thursday February 19, 2004. The number is 800- 642-1687, conference ID # 5441473. Physiometrix, Inc. designs, manufactures and markets noninvasive medical products -- based on novel gel materials, sophisticated signal-processing electronics technologies, and proprietary software -- for use in anesthesia- monitoring during surgical procedures. CONTACT: Daniel W. Muehl, CFO Physiometrix Inc. 978-670-2422

To: Michael P. Michaud who wrote (54668)	2/11/2004 9:20:45 AM
From: Pogeu Mahone	Respond to of 54805

well did you pick any PHYX up? what do you invest in? regards